FAM
HELP

Formidable Asset Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Formidable Asset Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Sell
10,217
-432
-4% -$2.16K 0.01% 384
2026
Q1 		$87.1K Buy
+10,649
New +$68.9K 0.01% 374
2024
Q3 		– Sell
-3,352
Closed -$34.5K – 375
2024
Q2 		$34.5K Buy
3,352
+345
+11% +$4.52K 0.01% 389
2024
Q1 		$47.2K Buy
3,007
+314
+12% +$4.54K 0.01% 384
2023
Q4 		$42K Buy
2,693
+421
+19% +$7.84K 0.01% 279
2023
Q3 		$45.9K Buy
2,272
+171
+8% +$2.52K 0.01% 279
2023
Q2 		$30K Buy
2,101
+302
+17% +$3.63K 0.01% 283
2023
Q1 		$26K Buy
1,799
+627
+53% +$10.2K 0.01% 303
2022
Q4 		$13K Buy
1,172
+184
+19% +$3.04K ﹤0.01% 311
2022
Q3 		$18K Sell
988
-26
-3% -$704 ﹤0.01% 299
2022
Q2 		$23K Sell
1,014
-39
-4% -$945 0.01% 303
2022
Q1 		$33K Buy
1,053
+419
+66% +$15.3K 0.01% 337
2021
Q4 		$29K Buy
634
+367
+137% +$23.2K 0.01% 314
2021
Q3 		$22K Buy
+267
New +$23.4K ﹤0.01% 357

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Formidable Asset Management's HELP Position: Q2 2026 in Review

Formidable Asset Management reduced its Helus Pharma Inc. Common Stock (HELP) stake by 4.1% in Q2 2026, selling an estimated $2.16K and leaving 10,217 shares worth $49K. The position accounts for 0.01% of the portfolio, ranked #384.

Formidable Asset Management first reported a position in HELP in Q3 2021 and has held it in 14 quarters since. The position peaked at $87.1K in Q1 2026. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Formidable Asset Management held 10,217 shares of Helus Pharma Inc. Common Stock worth $49K as of Q2 2026.
  • Formidable Asset Management sold 432 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $2.16K.
  • Helus Pharma Inc. Common Stock made up 0.01% of Formidable Asset Management's portfolio in Q2 2026, its #384 holding.
  • Formidable Asset Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 14 quarters since.
  • Formidable Asset Management's Helus Pharma Inc. Common Stock position peaked at $87.1K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Formidable Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.